Master's Thesis – Nanocarrier Development for Immune Cell Targeting (f/m/x)

At Helmholtz Munich, we develop groundbreaking solutions for a healthier society in a rapidly changing world. We believe that diverse perspectives drive innovation. Through strong partnerships, we accelerate the transfer of new ideas from the lab to real-life applications, improving lives.

At the Institute for Intelligent Biotechnologies (iBIO) our major goal is to accelerate biomedical research by developing and combining enabling technologies. Our major research fields are AI-based organ mapping, Tissue engineering and Precision medicine in cancer treatments. Sophisticated technologies such as 3D tissue imaging, molecular profiling are combined with AI tools to decode the complexity of tissues and shed light into cancer biology.

Our interdisciplinary team — comprising biologists, engineers, computer scientists, and medical researchers — develops next-generation computational models to interpret complex biomedical data across multiple scales. Our innovations in tissue clearing, 3D microscopy, and AI-driven pathology have been featured in leading journals (Nature Methods, Nature Neuroscience, Cell, Nature Biotechnology) and major media (The New York Times, Wall Street Journal, Süddeutsche Zeitung).

We are seeking a motivated Master's student (f/m/x) with a background in biochemistry, bioengineering, or a related field. The thesis project focuses on the development of lipid nanoparticle (LNP) libraries designed to achieve targeted delivery to immune cell populations.